SlideShare a Scribd company logo
Anti-Epileptic Drugs
Dr Kushagra Sharma
PharmD, RPh.
Epilepsies
 The group of disorder of the CNS characterized by
paroxysmal cerebral dysrhythmia, manifesting as brief
episodes (Seizures) of loss or disturbance of
consciousness, with or without body movement
(Convulsions), sensory or psychiatric phenomena.
 These episodes are unpredictable and their frequency is
highly variable.
 Recognised as “Disease of lightening” by JH Jackson.
Classification of Seizures
Generalized Seizures
 Generalized Tonic-Clonic
Seizures.
 Absence Seizures.
 Atonic Seizures.
 Myoclonic Seizures.
Partial Seizures
 Simple partial Seizures.
 Complex partial Seizures.
 Complex/Simple Partial
Seizure secondary
generalized.
Generalised Tonic-Clonic Seizures
 Major Epilepsy.
 Commonest
 Lasts about 1-2 min.
 Sequence is aura-cry-unconsciousness-tonic spasm of all body muscles-clonic
jerking followed by prolonged sleep and depression of all CNS functions.
Absence Seizures
 Minor Epilepsy.
 Prevalent in children
 Lasts about 1-2 min.
 Loss of consciousness, Patient freezes and stares at one direction, little
bilateral jerking.
 EEG shows 3 cycle per sec. wave length.
Atonic Seizures
 Akinetic Epilepsy.
 Sudden loss of postural tone.
 Patient ma fall off sudden.
 EEG shows diffused slow waves correlate with loss of muscle tone.
Myoclonic Seizures
 Sudden skeletal muscle contraction that may involve the entire body
or one part of the body.
 Patients complaints sudden jerking movements during sleep.
 EEG shows 2 Hz spikes and wave pattern per sec.
Simple Partial Seizures
 Also known as Jacksonian Seizures or Jacksonian motor Seizures .
 Begins with one group of muscles and spread gradually to adjacent
level.
 No loss of Consciousness.
 Patient may have symptoms like auditory, visual or olfactory
hallucinations, “Pins & Needle” sensations with no reason.
Complex Partial Seizures
 Partial loss of Consciousness.
 Patient behaves as partially conscious like- He may get up, put on his
clothes, start walking or even drive his car but does not follow your
command and does not even recollect the events after the attack is
over.
Complex/Simple Partial Seizure secondary generalized
 These are the type when partial seizers progress to
generalised/tonic/clonic/tonic-clonic seizures.
Classification of Anti-Epileptic Drugs
 Barbiturate -Phenobarbitone
 Deoxybarbiturate -Primidone
 Hydantoin -Phenytoin, Fosphenytoin
 Iminostilbene -Carbamazepin, Oxcarbazepin
 Succinimide -Ethosuximide
 Aliphatic Carboxylic Acid -Valproic acid(Sodium valproate),
Divalproex
 Benzodiazepines -Clonazepam, Diazepam, Lorazepam,
Clobazam
 Phenyltriazine -Lamotrigine
 Cyclic GABA analogous -Gabapentin, Pregabalin
 Newer Drugs -Topiramate, Zomisamide, Lacosamide,
Levetiracetam, Vigabetrin, Tiagabine
Phenobarbitone
 First Anti-Epileptic Drug, 1912.
Mechanism of Action:
 It primarily acts on GABA.
 Benzodiazepine (BZD) receptor- Cl- Channel complex and potentiate GABAergic
inhibition by using lifetime of Cl- Channel opening induced by GABA.
 Barbiturates act on alpha & beta sub units.
 It has anti-convulsant activity which is not entirely dependent on general CNS
depression.
 T- Half is 80 – 120 hours.
 Complete metabolized in liver and excretes unchanged from kidney.
 Steady state concentration can be reach in 2 – 3 weeks and single dose can be
used for maintenance.
 The major drawback is its sedative action.
Side Effects-
 Behavioural Abnormalities, Diminution of Intelligence, Impairment of learning
and memory, Hyperactivity in children, Mental Confusion, Rashes,
Megaloblastic Anaemia, Osteomalacia.
Uses-
 Cheapest and least toxic.
 Used in GTC, SP, CP, seizures in 60 mg as 1 to 3 times a day (Adults).
 3 to 5 mg per day for children (per Kg).
 Less popular due to its side effects.
Primidone-
 After administration it is converted by liver in phenobarbitone and phenyl
ethyl malonamide (PEMA).
 T – Half is 6 – 14 hours.
 1/3 of drug is eliminated by kidney.
 Frequently used in GTCS and Partial epilepsy.
Adverse Effect-
 Anaemia, Leukopenia, Psychotic reactions, lymph nodes enlargements.
Dose-
 250 – 500 mg BD (Adults).
 10 – 20 mg/kg/day (Children).
Phenytoin-
 Major Anti-Epileptic Drug, 1938.
 Not a CNS depressant.
 Drug of Choice.
 Toxic doses produce excitement & muscular rigidity.
 It limits spread of seizures.
 It should not inject with glucose solution (forms Ppts.).
Mechanism of Action
 It prolonged the inactivated state of voltage sensitive neuronal sodium
channel.
Pharmacokinetics-
 Absorption (Oral) is slow due to poor aqueous solubility.
 Distributed 80 – 90 % in a body.
 T- Half is 12 – 24 hours.
 Only 5% phenytoin excretes in urine (Unchanged).
Adverse Effect-
 Therapeutic Level- Gum Hypertrophy, acne, Hypersensitivity reactions,
Megaloblastic anaemia, Osteomalacia, Hyperglycaemia, Foetal hydration
syndrome (Pregnancy).
 Dose related Toxicity- Cerebellar & Vestibular Manifestation (Ataxia, Vertigo,
Diplopia), Drowsiness, behavioural alteration, mental confusion,
hallucination, epigastric pain, nausea, vomiting, low blood pressure, cardiac
arrhythmia(IV).
 Neurotoxicity due to steep raise in plasma concentration.
Uses-
 GTC, Simple & complex partial seizures.
Dose-
 100 – 400 mg/day (Adults), 5 – 8 mg/kg/day (Children).
Fosphenytoin-
 Water soluble product of phenytoin.
 Introduce to overcome difficulties in IV administration of phenytoin (used in
epileptics).
 Doses are phenytoin equivalents.
 Can be injected at faster rates (150 mg/min.).
 Required regular ECG monitoring.
 Injected by both saline & Glucose.
Dose-
 50 mg/ml in 2 ml, 10 ml injection.
Carbamazepine-
 In 1960s for trigeminal neuralgia.
 Chemically related to imipramine.
 First line drug.
 It inhibits kindling.
Pharmacokinetics-
 Oral absorption is slow.
 Poor water solubility.
 75 % bound with plasma protein & metabolized in liver by oxidation.
 T- Half is 20 – 40 hours.
Adverse Effect-
 Dose related neurotoxicity – Sedation, Dizziness, Vertigo, Diplopia, Ataxia.
 Vomiting, Diarrhoea, worsening of seizures with high dose.
 Acute Intoxication causes coma, convulsions, cardio collapse.
 Hypersensitivity reaction.
 Rarely agranulocytosis & aplastic anaemia.
Interactions-
 Oral Contraceptives, lamotrigine, Valproate & topiramate, Phenobarbitone,
Phenytoin, Erythromycin, Fluoxetine & Isoniazid.
Uses-
 CPS, GTCS & SPS.
Ethosuximide-
 Most prominent action is agonism of PTZs induced clonic seizures.
 Clinically it is effective only in absence seizures.
 It suppresses T current without affecting other types of calcium & sodium
currents.
 Does not potentiate GABA at therapeutic concentration.
Adverse Effect-
 Gastro – Intolerance, tiredness, mood changes, agitation, headache, drowsiness
& inability to concentrate.
Uses-
 Only used for absence seizures.
Doses-
20 – 30 mg/kg/day.
Valproic Acid
 Branched chai aliphatic carboxylic acic with broad spectrum anti – convulsant
action.
 More potent in PTZ Seizures.
 It shows little sedation.
 Effective in Partial seizure, GTCS, Absence seizures.
Mechanism of Action
 It acts by multiple mechanism-
1. Like Phenytoin (Prolongation of sodium channel inactivation).
2. Like Ethosuximide (Weak attenuation of calcium mediated T current).
Pharmacokinetics-
 Oral absorption is good.
 90 % bound to plasma protein, completely metabolized in liver by oxidation.
 T- Half is 10 – 15 Hours.
Adverse Effect-
 Toxicity is low.
 Anorexia, vomiting, loose motions & heartburn.
 Alopecia, curling of hair & increased bleeding tendency have been noticed.
Uses-
 Uses while pregnancy should be avoided.
 Drug of choice for absence seizures.
 Alternative drug for GTCS, SPS, CPS.
Interactions-
 Increases plasm level of phenobarbitone & lamotrigine by inhibiting their
metabolism.
 Phenytoin toxicity.
 Carbamazepine.
 Clonazepam & Valproic acid may for Ppts.
 Foetal abnormalities.
Clonazepam
 It is benzodiazepine with anti – convulsant properties.
 Blocks PTZ seizures at doses which produces mild sedation.
Mechanism of Action-
 It potentiate GABA induced Chlorine influx to produce sedation.
Pharmacokinetics-
 Oral absorption is good.
 85 % bound with plasma protein.
 T- Half is 24 Hours.
Adverse Effect-
 Sedation & Dullness, Lack of concentration, irritability, Temper & behavioural changes
in children.
 Salivation & Increase Respiratory secretion may be complained off.
Uses-
 Absence Seizures.
Dose-
 0.5 – 5 mg TDS (Adults).
 0.02 – 0.2 mg/kg/day (Children).
Choice of Drugs
SNo. Types of Seizures First Choice Second Choice Alternative
Choice
1. GTCS/ Simple partial with or
without generalised
Carbamazepine
Phenytoin
Valproate
Phenobarbitone
Gabapentin
Lamotrigine
Levetiracetam
Topiramate
Primidone
2. Complex partial with or
without generalized
Carbamazepine
Valproate
Phenytoin
Gabapentin
Lamotrigine
Levetiracetam
Clobazam
Topiramate
Zonisamide
3. Absence Valproate Ethosuximide
Lamotrigine
Levetiracetam
Clonazepam
4. Myoclonic Valproate Lamotrigine
Topiramate
Levetiracetam
Clonazepam
5. Atonic Valproate Clonazepam
Clobazam
Lamotrigine
6. Febrile Seizures Diazepam
(Rectal)
- -
7. Status Epilepticus Diazepam (IV)
Lorazepam (IV)
Fosphenytoin (IV)
Phenobarbitone
(IV or IM)
General
Anaesthesia
Thank You…

More Related Content

What's hot

Adrenergic drugs.
Adrenergic drugs.Adrenergic drugs.
Adrenergic drugs.
Md kawsar
 
Antihypertensives
AntihypertensivesAntihypertensives
Antihypertensives
raj kumar
 

What's hot (20)

Adrenergic drugs.
Adrenergic drugs.Adrenergic drugs.
Adrenergic drugs.
 
Sedatives & hypnotics
Sedatives & hypnoticsSedatives & hypnotics
Sedatives & hypnotics
 
Phenytoin
PhenytoinPhenytoin
Phenytoin
 
UNIT II SYMPATHOLYTIC AGENTS
UNIT II SYMPATHOLYTIC AGENTSUNIT II SYMPATHOLYTIC AGENTS
UNIT II SYMPATHOLYTIC AGENTS
 
Blood and plasma volume expanders
Blood and plasma volume expandersBlood and plasma volume expanders
Blood and plasma volume expanders
 
Levodopa
LevodopaLevodopa
Levodopa
 
Histamine and antihistaminics
Histamine and antihistaminicsHistamine and antihistaminics
Histamine and antihistaminics
 
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's DiseaseAnti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
 
Drugs acting on the blood and blood forming organs
Drugs acting on the blood and blood forming organsDrugs acting on the blood and blood forming organs
Drugs acting on the blood and blood forming organs
 
Antidepressant drugs
Antidepressant drugsAntidepressant drugs
Antidepressant drugs
 
Notes sedative & hypnotics
Notes sedative & hypnoticsNotes sedative & hypnotics
Notes sedative & hypnotics
 
Anti parkinsonian drugs
Anti parkinsonian drugsAnti parkinsonian drugs
Anti parkinsonian drugs
 
Antimanic drugs
Antimanic drugsAntimanic drugs
Antimanic drugs
 
Drugs used in Congestive heart failure
Drugs used in Congestive heart failure Drugs used in Congestive heart failure
Drugs used in Congestive heart failure
 
NSAID'S --ASPIRIN
NSAID'S --ASPIRINNSAID'S --ASPIRIN
NSAID'S --ASPIRIN
 
Antihypertensives
AntihypertensivesAntihypertensives
Antihypertensives
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
 
Antimanic drugs
Antimanic drugsAntimanic drugs
Antimanic drugs
 
Sedative hypnotics
Sedative  hypnoticsSedative  hypnotics
Sedative hypnotics
 
Antipsychotics - drdhriti
Antipsychotics - drdhritiAntipsychotics - drdhriti
Antipsychotics - drdhriti
 

Similar to Anti epileptic drugs

antiepileptics-160625053205.pptx
antiepileptics-160625053205.pptxantiepileptics-160625053205.pptx
antiepileptics-160625053205.pptx
RupaSingh83
 

Similar to Anti epileptic drugs (20)

39.ANTIEPILEPTIC DRUGS.ppt
39.ANTIEPILEPTIC DRUGS.ppt39.ANTIEPILEPTIC DRUGS.ppt
39.ANTIEPILEPTIC DRUGS.ppt
 
Introduction, Classification, general mechanism of action and pharmacology of...
Introduction, Classification, general mechanism of action and pharmacology of...Introduction, Classification, general mechanism of action and pharmacology of...
Introduction, Classification, general mechanism of action and pharmacology of...
 
Anti-epileptics
Anti-epilepticsAnti-epileptics
Anti-epileptics
 
antiepileptics-160625053205.pptx
antiepileptics-160625053205.pptxantiepileptics-160625053205.pptx
antiepileptics-160625053205.pptx
 
New Antiepileptic drugs Dr.Rahul.pptx
New Antiepileptic drugs Dr.Rahul.pptxNew Antiepileptic drugs Dr.Rahul.pptx
New Antiepileptic drugs Dr.Rahul.pptx
 
Pharmacology of Antiepileptic agents with
Pharmacology of Antiepileptic agents withPharmacology of Antiepileptic agents with
Pharmacology of Antiepileptic agents with
 
Premedication
PremedicationPremedication
Premedication
 
Antidepressant
AntidepressantAntidepressant
Antidepressant
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
 
Antiepileptic drugs prof satya
Antiepileptic drugs prof satya Antiepileptic drugs prof satya
Antiepileptic drugs prof satya
 
Drugs used in epilepsy.pptx by dr. nadira sultana
Drugs used in epilepsy.pptx by dr. nadira sultanaDrugs used in epilepsy.pptx by dr. nadira sultana
Drugs used in epilepsy.pptx by dr. nadira sultana
 
Psychopharmacology-copy.pptx
Psychopharmacology-copy.pptxPsychopharmacology-copy.pptx
Psychopharmacology-copy.pptx
 
Class sedatives and hypnotics 2
Class sedatives and hypnotics 2Class sedatives and hypnotics 2
Class sedatives and hypnotics 2
 
CNS PHARMACOLOGY.pptx
CNS PHARMACOLOGY.pptxCNS PHARMACOLOGY.pptx
CNS PHARMACOLOGY.pptx
 
Anti-epileptics
Anti-epilepticsAnti-epileptics
Anti-epileptics
 
Pharmacology of anti epileptic drugs
Pharmacology of anti epileptic drugsPharmacology of anti epileptic drugs
Pharmacology of anti epileptic drugs
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Disease
 
Status epilepticus management treatment
Status epilepticus management treatment Status epilepticus management treatment
Status epilepticus management treatment
 
Newer Anti Epileptic Drugs
Newer Anti Epileptic DrugsNewer Anti Epileptic Drugs
Newer Anti Epileptic Drugs
 
3) DRUG EFFECTIVE IN SEIZURE DISORDERS.ppt
3) DRUG EFFECTIVE IN SEIZURE DISORDERS.ppt3) DRUG EFFECTIVE IN SEIZURE DISORDERS.ppt
3) DRUG EFFECTIVE IN SEIZURE DISORDERS.ppt
 

Recently uploaded

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 

Recently uploaded (20)

Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
 
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
US E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complexUS E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complex
 
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
5cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +852975043415cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +85297504341
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 

Anti epileptic drugs

  • 1. Anti-Epileptic Drugs Dr Kushagra Sharma PharmD, RPh.
  • 2. Epilepsies  The group of disorder of the CNS characterized by paroxysmal cerebral dysrhythmia, manifesting as brief episodes (Seizures) of loss or disturbance of consciousness, with or without body movement (Convulsions), sensory or psychiatric phenomena.  These episodes are unpredictable and their frequency is highly variable.  Recognised as “Disease of lightening” by JH Jackson.
  • 3. Classification of Seizures Generalized Seizures  Generalized Tonic-Clonic Seizures.  Absence Seizures.  Atonic Seizures.  Myoclonic Seizures. Partial Seizures  Simple partial Seizures.  Complex partial Seizures.  Complex/Simple Partial Seizure secondary generalized.
  • 4. Generalised Tonic-Clonic Seizures  Major Epilepsy.  Commonest  Lasts about 1-2 min.  Sequence is aura-cry-unconsciousness-tonic spasm of all body muscles-clonic jerking followed by prolonged sleep and depression of all CNS functions. Absence Seizures  Minor Epilepsy.  Prevalent in children  Lasts about 1-2 min.  Loss of consciousness, Patient freezes and stares at one direction, little bilateral jerking.  EEG shows 3 cycle per sec. wave length.
  • 5. Atonic Seizures  Akinetic Epilepsy.  Sudden loss of postural tone.  Patient ma fall off sudden.  EEG shows diffused slow waves correlate with loss of muscle tone. Myoclonic Seizures  Sudden skeletal muscle contraction that may involve the entire body or one part of the body.  Patients complaints sudden jerking movements during sleep.  EEG shows 2 Hz spikes and wave pattern per sec.
  • 6. Simple Partial Seizures  Also known as Jacksonian Seizures or Jacksonian motor Seizures .  Begins with one group of muscles and spread gradually to adjacent level.  No loss of Consciousness.  Patient may have symptoms like auditory, visual or olfactory hallucinations, “Pins & Needle” sensations with no reason. Complex Partial Seizures  Partial loss of Consciousness.  Patient behaves as partially conscious like- He may get up, put on his clothes, start walking or even drive his car but does not follow your command and does not even recollect the events after the attack is over. Complex/Simple Partial Seizure secondary generalized  These are the type when partial seizers progress to generalised/tonic/clonic/tonic-clonic seizures.
  • 7. Classification of Anti-Epileptic Drugs  Barbiturate -Phenobarbitone  Deoxybarbiturate -Primidone  Hydantoin -Phenytoin, Fosphenytoin  Iminostilbene -Carbamazepin, Oxcarbazepin  Succinimide -Ethosuximide  Aliphatic Carboxylic Acid -Valproic acid(Sodium valproate), Divalproex  Benzodiazepines -Clonazepam, Diazepam, Lorazepam, Clobazam  Phenyltriazine -Lamotrigine  Cyclic GABA analogous -Gabapentin, Pregabalin  Newer Drugs -Topiramate, Zomisamide, Lacosamide, Levetiracetam, Vigabetrin, Tiagabine
  • 8. Phenobarbitone  First Anti-Epileptic Drug, 1912. Mechanism of Action:  It primarily acts on GABA.  Benzodiazepine (BZD) receptor- Cl- Channel complex and potentiate GABAergic inhibition by using lifetime of Cl- Channel opening induced by GABA.  Barbiturates act on alpha & beta sub units.
  • 9.  It has anti-convulsant activity which is not entirely dependent on general CNS depression.  T- Half is 80 – 120 hours.  Complete metabolized in liver and excretes unchanged from kidney.  Steady state concentration can be reach in 2 – 3 weeks and single dose can be used for maintenance.  The major drawback is its sedative action. Side Effects-  Behavioural Abnormalities, Diminution of Intelligence, Impairment of learning and memory, Hyperactivity in children, Mental Confusion, Rashes, Megaloblastic Anaemia, Osteomalacia. Uses-  Cheapest and least toxic.  Used in GTC, SP, CP, seizures in 60 mg as 1 to 3 times a day (Adults).  3 to 5 mg per day for children (per Kg).  Less popular due to its side effects.
  • 10. Primidone-  After administration it is converted by liver in phenobarbitone and phenyl ethyl malonamide (PEMA).  T – Half is 6 – 14 hours.  1/3 of drug is eliminated by kidney.  Frequently used in GTCS and Partial epilepsy. Adverse Effect-  Anaemia, Leukopenia, Psychotic reactions, lymph nodes enlargements. Dose-  250 – 500 mg BD (Adults).  10 – 20 mg/kg/day (Children).
  • 11. Phenytoin-  Major Anti-Epileptic Drug, 1938.  Not a CNS depressant.  Drug of Choice.  Toxic doses produce excitement & muscular rigidity.  It limits spread of seizures.  It should not inject with glucose solution (forms Ppts.). Mechanism of Action  It prolonged the inactivated state of voltage sensitive neuronal sodium channel.
  • 12. Pharmacokinetics-  Absorption (Oral) is slow due to poor aqueous solubility.  Distributed 80 – 90 % in a body.  T- Half is 12 – 24 hours.  Only 5% phenytoin excretes in urine (Unchanged). Adverse Effect-  Therapeutic Level- Gum Hypertrophy, acne, Hypersensitivity reactions, Megaloblastic anaemia, Osteomalacia, Hyperglycaemia, Foetal hydration syndrome (Pregnancy).  Dose related Toxicity- Cerebellar & Vestibular Manifestation (Ataxia, Vertigo, Diplopia), Drowsiness, behavioural alteration, mental confusion, hallucination, epigastric pain, nausea, vomiting, low blood pressure, cardiac arrhythmia(IV).  Neurotoxicity due to steep raise in plasma concentration. Uses-  GTC, Simple & complex partial seizures. Dose-  100 – 400 mg/day (Adults), 5 – 8 mg/kg/day (Children).
  • 13. Fosphenytoin-  Water soluble product of phenytoin.  Introduce to overcome difficulties in IV administration of phenytoin (used in epileptics).  Doses are phenytoin equivalents.  Can be injected at faster rates (150 mg/min.).  Required regular ECG monitoring.  Injected by both saline & Glucose. Dose-  50 mg/ml in 2 ml, 10 ml injection. Carbamazepine-  In 1960s for trigeminal neuralgia.  Chemically related to imipramine.  First line drug.  It inhibits kindling.
  • 14. Pharmacokinetics-  Oral absorption is slow.  Poor water solubility.  75 % bound with plasma protein & metabolized in liver by oxidation.  T- Half is 20 – 40 hours. Adverse Effect-  Dose related neurotoxicity – Sedation, Dizziness, Vertigo, Diplopia, Ataxia.  Vomiting, Diarrhoea, worsening of seizures with high dose.  Acute Intoxication causes coma, convulsions, cardio collapse.  Hypersensitivity reaction.  Rarely agranulocytosis & aplastic anaemia. Interactions-  Oral Contraceptives, lamotrigine, Valproate & topiramate, Phenobarbitone, Phenytoin, Erythromycin, Fluoxetine & Isoniazid. Uses-  CPS, GTCS & SPS.
  • 15. Ethosuximide-  Most prominent action is agonism of PTZs induced clonic seizures.  Clinically it is effective only in absence seizures.  It suppresses T current without affecting other types of calcium & sodium currents.  Does not potentiate GABA at therapeutic concentration. Adverse Effect-  Gastro – Intolerance, tiredness, mood changes, agitation, headache, drowsiness & inability to concentrate. Uses-  Only used for absence seizures. Doses- 20 – 30 mg/kg/day.
  • 16. Valproic Acid  Branched chai aliphatic carboxylic acic with broad spectrum anti – convulsant action.  More potent in PTZ Seizures.  It shows little sedation.  Effective in Partial seizure, GTCS, Absence seizures. Mechanism of Action  It acts by multiple mechanism- 1. Like Phenytoin (Prolongation of sodium channel inactivation). 2. Like Ethosuximide (Weak attenuation of calcium mediated T current). Pharmacokinetics-  Oral absorption is good.  90 % bound to plasma protein, completely metabolized in liver by oxidation.  T- Half is 10 – 15 Hours.
  • 17. Adverse Effect-  Toxicity is low.  Anorexia, vomiting, loose motions & heartburn.  Alopecia, curling of hair & increased bleeding tendency have been noticed. Uses-  Uses while pregnancy should be avoided.  Drug of choice for absence seizures.  Alternative drug for GTCS, SPS, CPS. Interactions-  Increases plasm level of phenobarbitone & lamotrigine by inhibiting their metabolism.  Phenytoin toxicity.  Carbamazepine.  Clonazepam & Valproic acid may for Ppts.  Foetal abnormalities.
  • 18. Clonazepam  It is benzodiazepine with anti – convulsant properties.  Blocks PTZ seizures at doses which produces mild sedation. Mechanism of Action-  It potentiate GABA induced Chlorine influx to produce sedation. Pharmacokinetics-  Oral absorption is good.  85 % bound with plasma protein.  T- Half is 24 Hours. Adverse Effect-  Sedation & Dullness, Lack of concentration, irritability, Temper & behavioural changes in children.  Salivation & Increase Respiratory secretion may be complained off. Uses-  Absence Seizures. Dose-  0.5 – 5 mg TDS (Adults).  0.02 – 0.2 mg/kg/day (Children).
  • 20. SNo. Types of Seizures First Choice Second Choice Alternative Choice 1. GTCS/ Simple partial with or without generalised Carbamazepine Phenytoin Valproate Phenobarbitone Gabapentin Lamotrigine Levetiracetam Topiramate Primidone 2. Complex partial with or without generalized Carbamazepine Valproate Phenytoin Gabapentin Lamotrigine Levetiracetam Clobazam Topiramate Zonisamide 3. Absence Valproate Ethosuximide Lamotrigine Levetiracetam Clonazepam 4. Myoclonic Valproate Lamotrigine Topiramate Levetiracetam Clonazepam 5. Atonic Valproate Clonazepam Clobazam Lamotrigine 6. Febrile Seizures Diazepam (Rectal) - - 7. Status Epilepticus Diazepam (IV) Lorazepam (IV) Fosphenytoin (IV) Phenobarbitone (IV or IM) General Anaesthesia